CRIB Blood Group: Historic Scientific Discovery
- A groundbreaking discovery in transfusion medicine has been made in India with the identification of a new human blood group named CRIB.
- The blood group was found in a woman from Kolar district, Karnataka, and had never before been documented anywhere in the world.
- The announcement was made at the 35th Regional Congress of the International Society of Blood Transfusion (ISBT) held in Milan, Italy.
What is the CRIB Blood Group?
- The CRIB blood group belongs to the Cromer (CR) blood group system.
- The name CRIB is derived from “CR” for Cromer and “IB” for India, Bangalore, acknowledging its place of discovery.
- It is characterized by a new antigen that had not been previously recognized in any global database.
- The antigen was identified after ten months of research and molecular testing by international transfusion science experts.
- The naming and recognition of this group were confirmed by the International Society of Blood Transfusion, the global authority for blood group classification.
Significance of the Discovery:
- The CRIB blood group represents a major advancement in transfusion medicine and immunohematology.
- It enhances global transfusion safety by expanding the catalogue of known blood group antigens.
- The identification helps in improving compatibility testing, particularly for patients who may have unusual antibodies.
- It also contributes to better donor-recipient matching, especially during organ transplants, complex surgeries, and emergency transfusions.
About the Cromer Blood Group System:
- The Cromer blood group system is associated with the Decay-Accelerating Factor (DAF), a protein found on red blood cells.
- It includes 12 high-prevalence antigens and 3 low-prevalence antigens.
- The newly discovered CRIB antigen expands this system further and helps fill existing gaps in immunohematology databases.
Understanding Rare Blood Types:
- A blood type is considered rare when it is found in less than 0.1 percent of the global population.
- Individuals with rare blood types may develop antibodies after transfusion or pregnancy, limiting their compatibility with most donors.
- Such patients can only receive blood from donors with the exact rare antigen profile.
- Rare blood groups pose challenges during blood transfusions, organ transplantation, and in managing autoimmune hemolytic disorders.
Conclusion:
- The discovery of the CRIB blood group marks a historic contribution from India to global medical science.
- It strengthens international efforts to ensure safer transfusion practices and provides new insights into the complexity of human blood diversity.
- This milestone underscores the importance of molecular testing and continued research in blood group science, particularly in underrepresented regions of the world.